NKARTA INC (NKTX) Stock Fundamental Analysis

NASDAQ:NKTX • US65487U1088

2.51 USD
+0.2 (+8.66%)
At close: Feb 24, 2026
2.52 USD
+0.01 (+0.4%)
After Hours: 2/24/2026, 7:43:57 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall NKTX gets a fundamental rating of 3 out of 10. We evaluated NKTX against 521 industry peers in the Biotechnology industry. NKTX has a great financial health rating, but its profitability evaluates not so good. NKTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NKTX had negative earnings in the past year.
  • In the past year NKTX has reported a negative cash flow from operations.
  • NKTX had negative earnings in each of the past 5 years.
  • In the past 5 years NKTX always reported negative operating cash flow.
NKTX Yearly Net Income VS EBIT VS OCF VS FCFNKTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • NKTX's Return On Assets of -24.02% is fine compared to the rest of the industry. NKTX outperforms 72.36% of its industry peers.
  • With a decent Return On Equity value of -30.37%, NKTX is doing good in the industry, outperforming 75.24% of the companies in the same industry.
Industry RankSector Rank
ROA -24.02%
ROE -30.37%
ROIC N/A
ROA(3y)-25.65%
ROA(5y)-27.09%
ROE(3y)-33.49%
ROE(5y)-32.64%
ROIC(3y)N/A
ROIC(5y)N/A
NKTX Yearly ROA, ROE, ROICNKTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NKTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NKTX Yearly Profit, Operating, Gross MarginsNKTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • NKTX has more shares outstanding than it did 1 year ago.
  • NKTX has more shares outstanding than it did 5 years ago.
  • NKTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NKTX Yearly Shares OutstandingNKTX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NKTX Yearly Total Debt VS Total AssetsNKTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -1.12, we must say that NKTX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of NKTX (-1.12) is comparable to the rest of the industry.
  • There is no outstanding debt for NKTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACCN/A
NKTX Yearly LT Debt VS Equity VS FCFNKTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 15.23 indicates that NKTX has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 15.23, NKTX belongs to the best of the industry, outperforming 92.13% of the companies in the same industry.
  • NKTX has a Quick Ratio of 15.23. This indicates that NKTX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 15.23, NKTX belongs to the best of the industry, outperforming 92.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.23
Quick Ratio 15.23
NKTX Yearly Current Assets VS Current LiabilitesNKTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • NKTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.60%, which is quite impressive.
EPS 1Y (TTM)26.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, NKTX will show a small growth in Earnings Per Share. The EPS will grow by 4.57% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.54%
EPS Next 2Y8.33%
EPS Next 3Y12.42%
EPS Next 5Y4.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NKTX Yearly Revenue VS EstimatesNKTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
NKTX Yearly EPS VS EstimatesNKTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NKTX. In the last year negative earnings were reported.
  • Also next year NKTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NKTX Price Earnings VS Forward Price EarningsNKTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NKTX Per share dataNKTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • NKTX's earnings are expected to grow with 12.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.33%
EPS Next 3Y12.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NKTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NKARTA INC

NASDAQ:NKTX (2/24/2026, 7:43:57 PM)

After market: 2.52 +0.01 (+0.4%)

2.51

+0.2 (+8.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-10
Earnings (Next)05-12
Inst Owners85.56%
Inst Owner Change-3.86%
Ins Owners0.28%
Ins Owner Change5.07%
Market Cap178.29M
Revenue(TTM)N/A
Net Income(TTM)-102.61M
Analysts83.08
Price Target12.04 (379.68%)
Short Float %9.31%
Short Ratio8.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.82%
Min EPS beat(2)9.26%
Max EPS beat(2)14.39%
EPS beat(4)4
Avg EPS beat(4)11.18%
Min EPS beat(4)4.19%
Max EPS beat(4)16.89%
EPS beat(8)6
Avg EPS beat(8)8.7%
EPS beat(12)9
Avg EPS beat(12)9.62%
EPS beat(16)11
Avg EPS beat(16)8.65%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.37
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.29
OCFYN/A
SpS0
BVpS4.76
TBVpS4.76
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.02%
ROE -30.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.65%
ROA(5y)-27.09%
ROE(3y)-33.49%
ROE(5y)-32.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.23
Quick Ratio 15.23
Altman-Z -1.12
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)770.74%
Cap/Depr(5y)709.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.64%
EPS Next Y16.54%
EPS Next 2Y8.33%
EPS Next 3Y12.42%
EPS Next 5Y4.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.72%
EBIT Next 3Y4.08%
EBIT Next 5Y2.85%
FCF growth 1Y26.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.89%
OCF growth 3YN/A
OCF growth 5YN/A

NKARTA INC / NKTX FAQ

What is the ChartMill fundamental rating of NKARTA INC (NKTX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NKTX.


What is the valuation status of NKARTA INC (NKTX) stock?

ChartMill assigns a valuation rating of 0 / 10 to NKARTA INC (NKTX). This can be considered as Overvalued.


What is the profitability of NKTX stock?

NKARTA INC (NKTX) has a profitability rating of 1 / 10.